Adaptive Biotechnologies Corporation (Nasdaq: ADPT) to Ring The Nasdaq Stock Market Opening Bell

NEXT STORY
Prolaris® Test Accurately Predicts Risk of Metastasis in Men Diagnosed with Localized Prostate Cancer
PREV STORY
Novavax and Catalent Biologics Enter Strategic Partnership: Allowing Catalent Biologics to Expand Gene Therapy Footprint with Acquisition of Novavax’ Manufacturing Assets and Capabilities
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aptose Biosciences Announces Results of Annual Meeting of Shareholders

SAN DIEGO and TORONTO, June 05, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” ...

author_avatar
NASDAQ Market News

Novartis drug Votubia® recommended by CHMP for EU approval to treat refractory partial-onset seizures in patients with TSC

If approved, Votubia would be the first adjunctive treatment specifically for refractory seizures in ...

author_avatar
NASDAQ Market News

IASLC convida profissionais da área do câncer de pulmão para participar da Pesquisa global sobre testes moleculares

Líder global em malignidade torácica conduz pesquisa para avaliar e melhorar os testes moleculares ...

author_avatar
NASDAQ Market News